Encelle encelle.com


Public lists: Pharma Startups (4732)

Encelle, Inc. (www.encelle.com) has developed novel products for tissue regeneration. The company has developed and patented an injectable biopolymer that is expected to have broad application for multiple therapeutic indications. Product development programs are under way in tendon and bone repair, dermal wound repair, cosmetic surgery, and dental applications. The company is located in Greenville, N.C.

Encelle, Inc. (www.encelle.com) has developed novel products for tissue regeneration. The company has developed and patented an injectable biopolymer that is expected to have broad application for multiple therapeutic indications. Product development...Show all

Company (Acquired)

Phone: 919-877-8101

Fax:

3000 Highwoods Boulevard
Suite 111
Raleigh, 27604
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Encelle $28.9M Jun 18, 2007
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Encelle Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

BrainCells

San Diego, California, United States
Alive / ActiveBrainCells is a biopharmaceutical company focused on the development of small molecule therapeutics for diseases of the central nervous system (CNS). The company's technology platform is based on research in the field of neurogenesis and recent discoveries linking neurogenesis to CNS disease states. BCI is using its neurogenesis technology platform to identify clinical-stage compounds, targets and compounds optimal for CNS indications. BCI is building a pipeline of clinical-stage programs to add...Show allLogin to see details

Spaltudaq

Seattle, Washington, United States
Alive / ActiveSpaltudaq Corporation, a privately-held biotechnology company based in Seattle, is focused on developing therapeutic antibodies for the treatment of inflammation, infectious disease and cancer. Our technology harnesses the power of the human immune system to identify tumor-specific or pathogen-specific monoclonal antibodies from human tissue samples.Login to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of preparing cross-linked bioactive hydrogel matrices May 18, 2010 Nov 08, 2011 Patent
Method of treating chronic ulcers May 30, 2001 Apr 20, 2010 Patent